Kolexia
Smith Denis Gastro-entérologie
Smith Denis
Gastro-entérologie
Hôpital Saint-André
Bordeaux, France
253 Activités
102 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Métastase tumorale Tumeurs neuroendocrines Carcinomes Adénocarcinome Tumeurs du foie Tumeurs du pancréas Instabilité des microsatellites Tumeurs du rectum

Collaborateurs

Voir plus
Guimbaud Rosine
Guimbaud Rosine
Hôpital Rangueil, Toulouse, France
Terrebonne Eric
Terrebonne Eric
Hôpital Haut-lévêque, Pessac, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France
Andre Thierry
Andre Thierry
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
Ipsen
49 collaboration(s)
Dernière en 2023
Servier
30 collaboration(s)
Dernière en 2023
Sanofi
12 collaboration(s)
Dernière en 2022
Advanced Accelerator Applications
11 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
MOUNTAINEER-03: An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer
Essai Clinique (Seagen)   15 mars 2024
SCARCE: A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Essai Clinique (Roche)   08 mars 2024
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
CLIMES: Circulating Tumor DNA in Patients With Colorectal Cancer Undergoing Curative-intent Surgery for Liver Metastases: Prospective, Multicenter, GERCOR Cohort
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   02 février 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   16 janvier 2024
Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
European journal of endocrinology   16 décembre 2023
OPALINE: AN OBSERVATIONAL REAL-WORLD STUDY OF THE SYSTEMIC TREATMENT OF WELL-DIFFERENTIATED, UNRESECTABLE OR METASTATIC, PROGRESSIVE PANCREATIC NEUROENDOCRINE TUMOURS (PNET): A STUDY OF MORBIDITY AND MORTALITY AT 2 YEARS
Essai Clinique (Pfizer)   09 novembre 2023
LBA7 Pembrolizumab versus chemotherapy in microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC): 5-year follow-up of the KEYNOTE-177 study Asia subgroup
Abstract Book of the ESMO Asia Congress 2023, 1-3 December 2023   01 novembre 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trial.
European journal of cancer (Oxford, England : 1990)   28 octobre 2023
NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU + Lenograstim) Followed by Chemoradiation (CRT) Based 5FU and Oxaliplatin and Surgery.
Cancer research and treatment   05 octobre 2023